BIOCRYST PHARMACEUTICALS INC Logo

BIOCRYST PHARMACEUTICALS INC

Develops novel medicines for patients with rare and serious diseases.

BCRX | US

Overview

Corporate Details

ISIN(s):
US09058V1035
LEI:
Country:
United States of America
Address:
4505 EMPEROR BOULEVARD, 27703 DURHAM

Description

BioCryst Pharmaceuticals Inc. is a commercial-stage biotechnology company dedicated to discovering, developing, and commercializing novel medicines for patients with rare and serious diseases. The company's primary focus is on hereditary angioedema (HAE), alongside other rare conditions. BioCryst utilizes its expertise in structure-guided drug design, a process that integrates advanced technologies with biology and medicinal chemistry, to create innovative therapies. It specializes in developing first-in-class or best-in-class oral small-molecule and protein therapeutics, aiming to provide more convenient and effective treatment options for patients.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-11 08:25
FORM 8-K
English 64.0 KB
2025-12-03 19:40
PRIMARY DOCUMENT
English 8.0 KB
2025-12-03 15:01 English 7.5 KB
2025-12-03 09:00
8-K
English 731.8 KB
2025-12-02 17:14
PRIMARY DOCUMENT
English 6.5 KB
2025-12-02 17:10
PRIMARY DOCUMENT
English 6.6 KB
2025-12-02 17:07
PRIMARY DOCUMENT
English 6.7 KB
2025-12-02 15:09 English 7.5 KB
2025-12-01 13:51 English 6.9 KB
2025-11-25 17:31 English 7.2 KB
2025-11-21 17:29 English 7.0 KB
2025-11-20 18:17
S-4
English 1.0 MB
2025-11-17 17:07
PRIMARY DOCUMENT
English 6.8 KB
2025-11-13 11:21 English 7.1 KB
2025-11-12 21:27 English 12.7 KB

Automate Your Workflow. Get a real-time feed of all BIOCRYST PHARMACEUTICALS INC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BIOCRYST PHARMACEUTICALS INC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for BIOCRYST PHARMACEUTICALS INC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Access Bio, Inc. Logo
Develops and manufactures in vitro diagnostic solutions for infectious diseases.
United States of America
950130
ACHIEVE LIFE SCIENCES, INC. Logo
A late-stage pharmaceutical company developing a treatment for nicotine dependence.
United States of America
ACHV
AC Immune SA Logo
Biopharmaceutical firm developing precision medicine for neurodegenerative diseases.
United States of America
ACIU
Aclaris Therapeutics, Inc. Logo
Clinical-stage biopharmaceutical company developing drugs for immuno-inflammatory diseases.
United States of America
ACRS
Acrivon Therapeutics, Inc. Logo
Clinical-stage biopharma using proteomics to develop precision oncology therapies.
United States of America
ACRV
Acticor Biotech Logo
Develops treatments for thrombotic diseases, focusing on acute ischemic stroke.
France
ALACT
Actinium Pharmaceuticals, Inc. Logo
Clinical-stage company developing targeted radiotherapies for difficult-to-treat cancers.
United States of America
ATNM
ACTUATE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing therapies for cancers with high unmet needs.
United States of America
ACTU
AcuCort AB Logo
Develops user-friendly drug formulations for severe and acute allergic reactions.
Sweden
ACUC
Acumen Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing targeted therapies for Alzheimer's disease.
United States of America
ABOS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.